Association Between Serum C1q Tumor Necrosis Factor-Related Protein 9 and the Clinical Characteristics and Prognosis of Ischemic Stroke
ConclusionsAll the findings indicated that serum CTRP9 could be a promising blood-derived biomarker for the early evaluation and prognosis assessment of IS.Trial RegistrationChinese Clinical Trial Registry, ChiCTR1800020330.
Source: Neurology and Therapy - Category: Neurology Source Type: research
More News: Brain | Cardiology | Cardiovascular | Cholesterol | Clinical Trials | Disability | Heart | Ischemic Stroke | Neurology | Statistics | Stroke | Study